DNAprint Genomics (DNAG)

[retired investor]

<<The data point in question however, is the report from the shareholders meeting held yesterday in which Dr Frudakis is quoted a saying there is no big money in classifiers.>>

agreed, the idea of actually being a drug co did not seem to be part of the earlier dream. from what i heard tony say (strictly my impression and conjecture) i think tony, in talking to big pharma and trying to partner with someone, came to the conclusion that helping them would be small potatoes. in fact, even came to realize that they would merely try to learn from his methods how to hold on to the status quo for their benefit. he came to the conclusion that what he knew and was working on with classifiers could really change the face of medicine as we know it; and, came to the conclusion that the way to do it wasn't to be in cahoots with big pharma.